OCT1 required for therapeutic effects of diabetes drug Metformin
The drug metformin is among the most widely prescribed drugs for the ...ic effects. Notably, these studies have shown that metformin acts by phosphorylating the enzyme AMPK, the cellular "energy-sensor", leading to a variety of cellu...JCI table of contents: May 1, 2007
...ic effects of diabetes drug Metformin The drug metformin is among the most widely prescribed drugs for the ...ic effects. Notably, these studies have shown that metformin acts by phosphorylating the enzyme AMPK, the cellular "energy-sensor", leading to a variety of cellu...Race affects medication adherence in type 2 diabetes
...ss of race, people who took the anti-diabetic drug metformin were 62 percent less likely to take the medication as prescribed. ...Traditional Chinese medicine for diabetes has scientific backing
...ent medicines for treating type 2 diabetes include metformin and the TZD group of drugs. However, alarge number of patients cannot tolerate metformin and the TZDs can cause undesirable weight gain.Therefore, it is critical to develop new therapies to...Treating obesity may improve the efficacy of therapy for hepatitis C
...sensitivity to insulin, such as the diabetes drugs metformin or pioglitazone, would lead to reduced fat accumulation in liver cells and might reverse disease progression. Third, increasing the dosages or the duration of combination therapy may increase circulating drug levels and improve drug efficacy. "Treatm...Takeda submits new drug application for extended-release type 2 diabetes medication, ACTOplus met
...medication ACTOplus met TM (pioglitazone HCl and metformin HCl) to the United States Food and Drug Administra...t with Andrx Corporation covering extended-release metformin in December 2003....Newer diabetic meds cost more, but users have fewer hospital visits
...ients who took thiazolidinediones (TZDs) or either metformin or a sulfonylurea to control their diabetes. TZDs ...scribed: 1,774 took a TZD, while 1,417 took either metformin or a sulfonylurea. The researchers collected information on total healthcare expenditures and hospit...Weight loss improves bladder control in women with prediabetes
... of type 2 diabetes by 58 percent. Treatment with metformin lowered the chances of developing diabetes by 31 p...ly assigned to intensive lifestyle changes, 636 to metformin treatment, and 661 to placebo. Their average age was 50 years old, with an average body mass index ...ACTOplus met (pioglitazone HCl and metformin HCl)
...ounced that ACTOplus met TM (pioglitazone HCl and metformin HCl) is now available by prescription in pharmacie...s not efficiently use the insulin it produces, and metformin acts primarily by reducing the amount of glucose produced by the liver. These medications work in c...PRESERVE- 2-year study of initial combo therapy with nateglinide or glyburide + metformin
...eceiving Starlix (nateglinide) in combination with metformin experienced equivalent levels of overall blood glu...ers also observed that treatment with Starlix plus metformin was weight neutral, while participants in the glyburide/metformin arm of the trial gained about 1 kg...NASH clinical research network launches trial for treatment of liver disease in children
...NAFLD. The participants will receive vitamin E, or metformin (an insulin-sensitizing drug), or placebo over 2 y...er disease. Results from small pilot studies using metformin or antioxidants for children with NAFLD appear to improve liver enzyme levels and may delay or possi...The Cochrane Library newsletter, 2005, issue 3
...trials, the Cochrane Review Authors concluded that metformin works well as a single-drug therapy for many peopl...weight, had type 2 diabetics and were on intensive metformin were also less likely to be affected by stroke, heart attacks, and are less likely to die. The autho...Diabetes drug controls blood glucose, cardiac risk
A new review of studies confirms that the drug metformin should be in the first line of defense against type 2 diabetes. Using metformin alone can improve control of blood glucose, while also reducing risk factors for heart disease such ...Takeda submits new drug application for combination type 2 diabetes medication
...rate NDA for a combination of pioglitazone HCl and metformin HCl in October 2004. ACTOS (pioglitazone HCl) directly targets insulin resistance, a condition in which the body does not efficiently use the insulin it produces. Glimepiride acts primarily by increasing the amount of insulin produced by the pancre......on track. The participants originally assigned to metformin therapy continue to have access to the drug. RETINOPATHY FINDINGS Three hundred two, or about 12 percent, of the DPP Outcome Study participants who had not developed diabetes during the study, and 588 of 876 participants who had developed diabetes...